Evidence map›Paper›PMID 27223611›Full record

ArticlePloS one2016

The Pharmacochaperone Activity of Quinine on Bitter Taste Receptors.

Jasbir D Upadhyaya, Raja Chakraborty, Feroz A Shaik, Appalaraju Jaggupilli, Rajinder P Bhullar, Prashen Chelikani

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. GengricinInternational journal of molecular sciences · 2024
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Pharmacology of T2R Mediated Host-Microbe Interactions.Handbook of experimental pharmacology · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. G3 (Bethesda, Md.) · 2018
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jasbir D UpadhyayaDepartment of Oral Biology, and Manitoba Chemosensory Biology (MCSB) Research group, University of Manitoba, Winnipeg, MB, R3E 0W2, Canada.
Raja ChakrabortyDepartment of Oral Biology, and Manitoba Chemosensory Biology (MCSB) Research group, University of Manitoba, Winnipeg, MB, R3E 0W2, Canada.
Feroz A ShaikDepartment of Oral Biology, and Manitoba Chemosensory Biology (MCSB) Research group, University of Manitoba, Winnipeg, MB, R3E 0W2, Canada.
Appalaraju JaggupilliDepartment of Oral Biology, and Manitoba Chemosensory Biology (MCSB) Research group, University of Manitoba, Winnipeg, MB, R3E 0W2, Canada.
Rajinder P BhullarDepartment of Oral Biology, and Manitoba Chemosensory Biology (MCSB) Research group, University of Manitoba, Winnipeg, MB, R3E 0W2, Canada.
Prashen ChelikaniDepartment of Oral Biology, and Manitoba Chemosensory Biology (MCSB) Research group, University of Manitoba, Winnipeg, MB, R3E 0W2, Canada.
Children's Hospital Research Institute of Manitoba · CAUniversity of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bitter taste is one of the five basic taste sensations which is mediated by 25 bitter taste receptors (T2Rs) in humans. The mechanism of bitter taste signal transduction is not yet elucidated. The cellular processes underlying T2R desensitization including receptor internalization, trafficking and degradation are yet to be studied. Here, using a combination of molecular and pharmacological techniques we show that T2R4 is not internalized upon agonist treatment. Pretreatment with bitter agonist quinine led to a reduction in subsequent quinine-mediated calcium responses to 35 ± 5% compared to the control untreated cells. Interestingly, treatment with different bitter agonists did not cause internalization of T2R4. Instead, quinine treatment led to a 2-fold increase in T2R4 cell surface expression which was sensitive to Brefeldin A, suggesting a novel pharmacochaperone activity of quinine. This phenomenon of chaperone activity of quinine was also observed for T2R7, T2R10, T2R39 and T2R46. Our results suggest that the observed action of quinine for these T2Rs is independent of its agonist activity. This study provides novel insights into the pharmacochaperone activity of quinine and possible mechanism of T2R desensitization, which is of fundamental importance in understanding the mechanism of bitter taste signal transduction.

Indexed as

Brefeldin ACalciumCell MembraneGene Expression RegulationHEK293 CellsHumansModels, MolecularQuinineReceptors, G-Protein-CoupledSignal TransductionTasteTaste Receptors, Type 2Brefeldin ACalciumQuinineReceptors, G-Protein-CoupledTaste Receptors, Type 2

Identifiers

PMID27223611
PMCPMC4880206
OpenAlexW2395836636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.